Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

Jan 29 2026 08:01 AM IST
share
Share Via
Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in its share price, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a complex but cautiously optimistic outlook for investors.
Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

The stock closed at ₹2,132.65 on 29 Jan 2026, down 0.70% from the previous close of ₹2,147.60. Intraday volatility saw a high of ₹2,159.15 and a low of ₹2,116.50, reflecting some short-term uncertainty. The 52-week range remains between ₹1,774.00 and ₹2,228.35, indicating that the current price is closer to the upper band of its annual trading range.

Technically, Lupin’s trend has softened from a strong bullish posture to a mildly bullish one. This subtle shift is evident in the weekly and monthly technical indicators, which present a mixed picture of momentum and trend strength.

MACD Signals: Divergence Between Weekly and Monthly Trends

The Moving Average Convergence Divergence (MACD) indicator remains bullish on the weekly chart, signalling that short-term momentum is still positive. However, the monthly MACD has turned mildly bearish, suggesting that longer-term momentum is weakening. This divergence implies that while the stock may continue to see short-term gains, investors should be cautious about potential medium-term corrections or consolidation phases.

RSI and Momentum Oscillators: Bearish Weekly RSI Contrasts with Neutral Monthly Readings

The Relative Strength Index (RSI) on the weekly timeframe has slipped into bearish territory, indicating that the stock may be experiencing some short-term selling pressure or loss of upward momentum. Conversely, the monthly RSI shows no clear signal, reflecting a neutral stance over the longer term. This disparity highlights the importance of monitoring the stock closely for any further RSI deterioration that could signal a deeper correction.

Moving Averages and Bollinger Bands: Daily Bullishness and Monthly Strength

Daily moving averages continue to support a bullish outlook, with the stock price trading above key averages, reinforcing short-term strength. Bollinger Bands add further nuance: weekly bands are mildly bullish, suggesting moderate upward price volatility, while monthly bands remain bullish, indicating sustained longer-term price expansion potential.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Additional Technical Indicators: KST, Dow Theory, and OBV

The Know Sure Thing (KST) oscillator presents a bullish signal on the weekly chart but turns mildly bearish on the monthly timeframe, mirroring the MACD’s mixed momentum signals. Dow Theory assessments also reflect this duality, with weekly readings mildly bearish and monthly readings mildly bullish, underscoring the stock’s current indecision between short-term weakness and longer-term strength.

On the volume front, the On-Balance Volume (OBV) indicator shows no clear trend weekly but is mildly bullish monthly, suggesting that accumulation may be occurring over the longer term despite recent short-term selling pressure.

Comparative Returns: Lupin vs. Sensex

Examining Lupin’s returns relative to the Sensex provides valuable context for its performance. Over the past week, Lupin’s stock declined by 0.32%, while the Sensex gained 0.53%. However, over the past month and year-to-date, Lupin outperformed the Sensex with returns of 0.93% and 0.98% respectively, compared to Sensex declines of 3.17% and 3.37%. Over longer horizons, Lupin’s performance is notably superior, with a five-year return of 103.06% versus the Sensex’s 75.67%, and a three-year return of 187.34% compared to 38.79% for the benchmark. This outperformance highlights Lupin’s strong fundamental and sectoral positioning despite recent technical fluctuations.

Mojo Score and Rating Update

MarketsMOJO has recently downgraded Lupin’s mojo grade from Strong Buy to Buy as of 28 Jan 2026, reflecting the tempered technical momentum and mixed indicator signals. The mojo score stands at a robust 74.0, signalling overall positive sentiment but with caution advised given the evolving technical landscape. The market cap grade remains at 1, indicating Lupin’s status as a large-cap stock with significant market presence and liquidity.

Investment Implications and Outlook

For investors, Lupin’s current technical profile suggests a cautious approach. The bullish daily moving averages and monthly Bollinger Bands support the potential for continued upward movement, but the bearish weekly RSI and monthly MACD warn of possible short-term corrections or consolidation. The divergence between weekly and monthly indicators emphasises the importance of a multi-timeframe analysis to balance short-term risks with longer-term opportunities.

Given Lupin’s strong historical returns relative to the Sensex and its solid mojo score, the stock remains an attractive proposition for investors with a medium to long-term horizon. However, those with shorter-term trading strategies should monitor key technical levels closely, particularly the weekly RSI and MACD signals, to manage downside risk effectively.

Lupin Ltd. caught your attention? Explore our comprehensive research report with in-depth analysis of this large-cap Pharmaceuticals & Biotechnology stock – fundamentals, valuations, financials, and technical outlook!

  • - Comprehensive research report
  • - In-depth large-cap analysis
  • - Valuation assessment included

Explore In-Depth Research →

Summary

Lupin Ltd.’s technical momentum has shifted to a mildly bullish stance, reflecting a complex interplay of short-term weakness and longer-term strength. Mixed signals from MACD, RSI, moving averages, and other indicators suggest that while the stock retains upside potential, investors should remain vigilant for possible short-term corrections. The company’s strong relative returns and mojo score underpin its appeal as a buy-rated large-cap stock in the Pharmaceuticals & Biotechnology sector. Careful monitoring of technical developments will be key to navigating Lupin’s evolving market dynamics.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News